Health Care
Blog
Read how Biden plan would hurt medical innovation
The Biden Administration Abuses Inflation to Attack Medical Innovation
It is theoretically bankrupt because price changes for individual goods and services reflect unique market factors in addition to broad-based inflation trends. There is no reason to expect any good’s price changes to always equal the average of all price changes (e.g., measured inflation). For instance, a deep frost that ...
Commentary
Reining in the true culprit behind critical medicine shortages
Drug shortages in the United States have reached crisis levels. The Food and Drug Administration reports that nearly 140 medicines are currently in short supply. That figure includes more than a dozen cancer drugs, which has forced doctors and patients to confront the dangerous possibility of rationing. These shortages threaten ...
Commentary
How 2024 Republican presidential candidates should talk about healthcare
Republican presidential candidates are once again talking about healthcare policy. At a debate earlier this month, Gov. Ron DeSantis (R-FL) discussed the need for more affordable healthcare. Vivek Ramaswamy called for a more competitive insurance marketplace. The renewed interest in healthcare among Republicans came on the heels of former President Donald Trump’s assertion that he’d seriously look at replacing ...
Commentary
Read Sally Pipes' latest at Newsmax
GOP Shouldn’t Squander Trump’s Revival of Obamacare Debate
Former President Donald Trump recently revealed he is “seriously looking at alternatives” to Obamacare. As he put it in a post on Truth Social, “[t]he cost of Obamacare is out of control, plus, it’s not good Healthcare.” Those comments should have come as good news to lawmakers looking to reduce the ...
Commentary
Giving The Gov’t Drug Patent March-In Authority Is Bad Policy
In early December, the Biden administration announced a proposal on exercising march-in rights on taxpayer-funded drugs and other inventions that allows prices to “be a factor in considering whether a drug is accessible to the public.” This is a terrible idea. As the Congressional Research Service summarized, it is an ...
Commentary
Read Sally Pipes' latest at Forbes
There’s Nothing Crazy About Donald Trump’s Pledge To Replace Obamacare
Former President Donald Trump made waves late last month when he announced that he was “seriously looking” at replacing Obamacare if elected to a second term. Democrats’ reaction to this announcement was unsurprising. President Joe Biden leapt into action to defend his former boss’s signature healthcare law, claiming that Trump’s plan would “rip away ...
Commentary
Elizabeth Warren talks turkey about Obamacare’s perverse incentives
Two days before Thanksgiving, Sen. Elizabeth Warren (D-MA) sent a letter with her colleague Sen. Mike Braun (R-IN) asking the U.S. Department of Health and Human Services to investigate the impact of Obamacare’s medical loss ratio rules on insurer consolidation. It’s a striking, if tacit, admission of the law’s flaws by one of the nation’s leading ...
Commentary
Will Trump’s Hospital Price Transparency Rule Resurge?
One of President Donald J. Trump’s greatest health-policy coups during his term in office came in 2019. His executive order directed hospitals to disclose the prices of a range of services and treatments. The logic behind the order was straightforward. In order for healthcare markets to function efficiently, patients need ready access ...
Commentary
Reforming PBM Practices Would Improve The Pharmacy Market
Patients, the ultimate healthcare arbiter, continue to bear the costs from the perverse incentives driving the pharmacy benefit manager (PBM) market. Because of these disincentives patients pay excessive out-of-pocket costs. Just as troubling, the misaligned incentives create impediments that dictate where patients can fill their prescriptions and which prescriptions they can ...
Read how Biden plan would hurt medical innovation
The Biden Administration Abuses Inflation to Attack Medical Innovation
It is theoretically bankrupt because price changes for individual goods and services reflect unique market factors in addition to broad-based inflation trends. There is no reason to expect any good’s price changes to always equal the average of all price changes (e.g., measured inflation). For instance, a deep frost that ...
Reining in the true culprit behind critical medicine shortages
Drug shortages in the United States have reached crisis levels. The Food and Drug Administration reports that nearly 140 medicines are currently in short supply. That figure includes more than a dozen cancer drugs, which has forced doctors and patients to confront the dangerous possibility of rationing. These shortages threaten ...
How 2024 Republican presidential candidates should talk about healthcare
Republican presidential candidates are once again talking about healthcare policy. At a debate earlier this month, Gov. Ron DeSantis (R-FL) discussed the need for more affordable healthcare. Vivek Ramaswamy called for a more competitive insurance marketplace. The renewed interest in healthcare among Republicans came on the heels of former President Donald Trump’s assertion that he’d seriously look at replacing ...
Read Sally Pipes' latest at Newsmax
GOP Shouldn’t Squander Trump’s Revival of Obamacare Debate
Former President Donald Trump recently revealed he is “seriously looking at alternatives” to Obamacare. As he put it in a post on Truth Social, “[t]he cost of Obamacare is out of control, plus, it’s not good Healthcare.” Those comments should have come as good news to lawmakers looking to reduce the ...
Giving The Gov’t Drug Patent March-In Authority Is Bad Policy
In early December, the Biden administration announced a proposal on exercising march-in rights on taxpayer-funded drugs and other inventions that allows prices to “be a factor in considering whether a drug is accessible to the public.” This is a terrible idea. As the Congressional Research Service summarized, it is an ...
Read Sally Pipes' latest at Forbes
There’s Nothing Crazy About Donald Trump’s Pledge To Replace Obamacare
Former President Donald Trump made waves late last month when he announced that he was “seriously looking” at replacing Obamacare if elected to a second term. Democrats’ reaction to this announcement was unsurprising. President Joe Biden leapt into action to defend his former boss’s signature healthcare law, claiming that Trump’s plan would “rip away ...
Elizabeth Warren talks turkey about Obamacare’s perverse incentives
Two days before Thanksgiving, Sen. Elizabeth Warren (D-MA) sent a letter with her colleague Sen. Mike Braun (R-IN) asking the U.S. Department of Health and Human Services to investigate the impact of Obamacare’s medical loss ratio rules on insurer consolidation. It’s a striking, if tacit, admission of the law’s flaws by one of the nation’s leading ...
Will Trump’s Hospital Price Transparency Rule Resurge?
One of President Donald J. Trump’s greatest health-policy coups during his term in office came in 2019. His executive order directed hospitals to disclose the prices of a range of services and treatments. The logic behind the order was straightforward. In order for healthcare markets to function efficiently, patients need ready access ...
Reforming PBM Practices Would Improve The Pharmacy Market
Patients, the ultimate healthcare arbiter, continue to bear the costs from the perverse incentives driving the pharmacy benefit manager (PBM) market. Because of these disincentives patients pay excessive out-of-pocket costs. Just as troubling, the misaligned incentives create impediments that dictate where patients can fill their prescriptions and which prescriptions they can ...
